Owlet, Inc. - OWLT STOCK NEWS

Owlet (NYSE: OWLT), a smart infant monitoring company, announces participation in two upcoming virtual investor conferences. At the Sidoti Micro Cap Conference on November 14, 2024, CEO Kurt Workman and CFO Amanda Twede Crawford will present at 12:15 p.m. ET. At the BTIG Digital Health Forum on November 25, 2024, Workman will join a panel discussion on 'The Consumer as a Patient' at 8:00 a.m. ET, followed by a fireside chat at 9:00 a.m. ET. Both events offer one-on-one meetings with investors, and the Sidoti presentation will be available via webcast on Owlet's Investor Relations website.

Owlet (NYSE: OWLT), a pioneer in smart infant monitoring, has scheduled its third quarter 2024 financial results announcement for November 13, 2024, after market close. The company will host a conference call at 4:30 p.m. ET featuring CEO Kurt Workman, President Jonathan Harris, and CFO Amanda Twede Crawford. Investors can join via phone at 833-470-1428 (domestic) or 404-975-4839 (international) using Access Code 626609, or through the webcast on Owlet's Investor Relations website.

Owlet, Inc. (NYSE:OWLT), a pioneer in smart infant monitoring, has regained compliance with the NYSE's continued listing standards. The company had previously been notified on April 4, 2023, that it was not in compliance with Section 802.01B of the NYSE Listed Company Manual due to its average global market capitalization falling below $50 million over a consecutive 30-day trading period, while simultaneously reporting stockholders' equity below $50 million.

As a result of achieving compliance with the NYSE's minimum market capitalization requirement, Owlet is no longer considered out of compliance with these standards. The 'BC' (below compliance) indicator has been removed from the company's Class A common stock, and Owlet is no longer listed as being below continued listing standards on the NYSE website. The company will be subject to a 12-month follow-up period to ensure ongoing compliance with the NYSE's continued listing standards.

Owlet, Inc. (NYSE:OWLT) has released its State of Parenting Report, highlighting the challenges faced by parents during their baby's first year. The study reveals that exhaustion (61%) is the most common emotion experienced by parents, followed by feeling overwhelmed (48%) and anxious (32%). On average, parents lose three hours of sleep per night, with 86% waking up to eight times nightly to check on their baby.

Key findings include:

• Nearly 40% of parents worry most about their newborn contracting illnesses or SIDS
• 53% report getting little to no sleep
• 74% feel less stressed and anxious with baby monitoring technology
• 50% want a monitor to help determine when to seek medical attention

The report emphasizes the need for solutions to support parents, with Owlet's Dream Sock® providing reassurance to 96% of users surveyed.

Owlet (NYSE:OWLT), a smart infant monitoring company, has announced the pricing of a public offering and a comprehensive debt refinancing, aiming to raise up to $46.6 million in total gross proceeds. The public offering consists of 3,135,136 shares of Class A common stock priced at $3.70 per share, expected to generate approximately $11.6 million. The debt refinancing includes a term loan agreement with Western Technology Investment for up to $15 million and a revolving credit facility with Mountain Ridge Capital for up to $15-20 million. Owlet plans to use the proceeds for general corporate purposes, capital expenditures, and working capital.

Owlet, Inc. (NYSE:OWLT), a pioneer in smart infant monitoring, has announced plans for a public offering of its Class A common stock. The company intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the gross proceeds. Titan Partners Group, a division of American Capital Partners, is acting as the sole bookrunner for the offering.

Owlet plans to use the net proceeds for general corporate purposes, capital expenditures, working capital, and general and administrative expenses. The offering is subject to market conditions, and there's no guarantee of its completion or terms. The securities will be offered through an effective shelf registration statement on Form S-3 previously filed with the SEC.

Owlet (NYSE:OWLT) announced at Kind + Jugend in Cologne, Germany, that its medically-certified Dream Sock will soon be available in more European countries, including Poland, Greece, and the Czech Republic. The Dream Sock is a CE and UKCA Marked smart digital health infant monitoring device that tracks pulse rate, oxygen saturation, and sleep patterns for babies aged 0-18 months.

The device connects to the Owlet Dream App, providing real-time health readings and immediate notifications for abnormal vital signs. Owlet's CEO, Kurt Workman, emphasized the impact Dream Sock has already made on thousands of families since its global launch. The company is attending Kind + Jugend to meet with current and potential distribution partners to showcase their latest technology.

Bronstein, Gewirtz & Grossman, is investigating potential claims against Sandbridge Acquisition , which merged with Owlet, Inc. (NYSE:OWLT) on July 15, 2021. The investigation focuses on whether Sandbridge failed to provide relevant information to shareholders before the merger. Investors who purchased Sandbridge shares before June 1, 2021, and still hold Owlet shares are encouraged to participate. The law firm is conducting this investigation on a contingency fee basis, meaning fees are only charged if the case is successful. Interested parties can contact Peretz Bronstein or Nathan Miller at 332-239-2660 for more information.

Bronstein, Gewirtz & Grossman, is investigating potential claims against Sandbridge Acquisition , which merged with Owlet, Inc. (NYSE:OWLT) on July 15, 2021. The investigation focuses on whether Sandbridge failed to provide relevant information to shareholders before the merger. Investors who purchased Sandbridge shares before June 1, 2021, and still hold Owlet shares are encouraged to participate in the investigation.

The law firm is representing investors on a contingency fee basis, meaning they will only seek reimbursement for expenses and fees if successful. Bronstein, Gewirtz & Grossman, has a track record of recovering millions for investors in securities fraud class actions and shareholder derivative suits.